anemia in elderly market, anemia in elderly market share, anemia in elderly market growth, anemia in elderly market forecast, anemia in elderly market trends, us anemia in elderly market
What are the latest figures on the anemia in elderly market’s size and projected CAGR?
The anemia in elderly market size has grown strongly in recent years. It will grow from $2.75 billion in 2024 to $3.02 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to nutritional deficiencies, chronic diseases, inflammation, bone marrow disorders, and blood loss.
The anemia in elderly market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to aging population, rising prevalence of chronic diseases, advancements in diagnostic tools, increasing healthcare awareness, and improved access to treatment. Major trends in the forecast period include AI-driven diagnostics, wearable health monitors, advanced blood analysis tools, telehealth integration, and personalized medicine solutions.
Get Your Free Sample of The Global Anemia In Elderly Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp
Which Market drivers have played a significant role in driving the anemia in elderly market?
The growing elderly population is expected to propel the growth of the anemia in the elderly market going forward. The elderly population is the increasing number and proportion of people aged 65 and older within a given society or globally. The growth of the elderly population is due to factors including increased life expectancy, declining birth rates, and aging of large cohorts. The growing elderly population increases the prevalence of age-related and chronic conditions, which are significant causes of anemia in older adults. This drives the demand for diagnosis, management, and treatment of anemia, fueling market growth. For instance, in July 2024, according to the Office for National Statistics (ONS), a UK-based governmental organization, the number of people aged 65 or over in the UK increased to 12.7 million in 2022 from 11 million in 2021. Therefore, the growing elderly population is driving the growth of the anemia in elderly market.
What are the key segments within the anemia in elderly market?
The anemia in elderly market covered in this report is segmented –
1) By Product Type: Tablets, Injectable
2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements
3) By Route Of Administration: Oral, Parenteral
4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy
Subsegments:
1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets
2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report
Which key players are shaping the anemia in elderly market?
Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd
Which transformative trends will shape the anemia in elderly market landscape?
Major companies operating in the anemia in the elderly market are focusing on technological advancements, such as personalized therapies, to streamline treatment processes, improve patient outcomes, reduce side effects, and enhance overall healthcare efficiency. Customized therapies are medical treatments based on each patient’s individual characteristics. For instance, in March 2024, Cadila Pharmaceuticals, an Indian-based pharmaceutical company, announced the launch of Redshot FCM, a novel iron injection designed to treat iron deficiency anemia for patients who experience oral iron intolerance. It is intravenous iron preparation that delivers adequate amounts of iron and boosts an exemplary safety profile. The injection features an advanced Ferric Carboxymaltose formulation that improves iron delivery and absorption. Redshot FCM demonstrates a dedication to improving healthcare by developing personalized therapies that account for individual patient profiles, leading to better treatment outcomes for iron deficiency anemia.
How do regional factors impact the anemia in elderly market, and which region is the largest contributor?
North America was the largest region in the anemia in elderly market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Anemia In Elderly Market Report 2025 Offer?
The anemia in elderly market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Anemia in the elderly refers to a condition characterized by a reduction in the number of red blood cells (RBCs) or hemoglobin levels below the normal range, leading to diminished oxygen-carrying capacity of the blood in older adults (commonly defined as individuals aged 65 years and older). It is often caused by nutritional deficiencies, chronic diseases, or age-related changes in the body.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20711
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
